STK11/LKB1 Mutation-positive Primary Thymic Mucinous Adenocarcinoma Accompanied by Cerebellar Metastasis: A Case Report and Literature Review

Affiliations

¹ Respiratory Disease Center, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama City, Kanagawa, Japan; Division of Chest Surgery, Department of Surgery, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan. Electronic address: himuro0824@med.showa-u.ac.jp.
² Respiratory Disease Center, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama City, Kanagawa, Japan.
³ Department of Clinical Pathology, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama City, Kanagawa, Japan.
⁴ Division of Chest Surgery, Department of Surgery, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan.

Review

Naoya Himuro et al. Clin Lung Cancer. 2021 Sep.

. 2021 Sep;22(5):e659-e664.

doi: 10.1016/j.cllc.2020.10.010. Epub 2020 Oct 21.

¹ Respiratory Disease Center, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama City, Kanagawa, Japan; Division of Chest Surgery, Department of Surgery, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan. Electronic address: himuro0824@med.showa-u.ac.jp.
² Respiratory Disease Center, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama City, Kanagawa, Japan.
³ Department of Clinical Pathology, Showa University Northern Yokohama Hospital, Tsuzuki-ku, Yokohama City, Kanagawa, Japan.
⁴ Division of Chest Surgery, Department of Surgery, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan.

No abstract available

Keywords: FDG-PET; Radiotherapy; Surgical resection; Thymic cancer; mTOR inhibitors.

Publication types